Literature DB >> 9519928

Cystic fibrosis: bilateral living lobar versus cadaveric lung transplantation.

R G Barbers1.   

Abstract

Living donor transplantation is now an acceptable option that should be considered for selected cystic fibrosis patients with end-stage lung disease. Two lungs obtained from live donors can adequately support an adult cystic fibrosis patient. The morbidity from lobectomy to the healthy donor is minimal.

Entities:  

Mesh:

Year:  1998        PMID: 9519928     DOI: 10.1097/00000441-199803000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis.

Authors:  L Gee; J Abbott; S P Conway; C Etherington; A K Webb
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  Live related donor lobar lung transplantation recipients surviving well over a decade: still an option in times of advanced donor management.

Authors:  Prashant N Mohite; Aron F Popov; Magdi H Yacoub; Andre R Simon
Journal:  J Cardiothorac Surg       Date:  2013-03-07       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.